Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver - ScienceDirect
Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease
Art 3 Non-Alcoholic Fatty Liver Disease A, PDF, Hepatitis
Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease
Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. - Abstract - Europe PMC
Membrane-bound O-acyltransferase 7 (MBOAT7)-driven phosphatidylinositol remodeling in advanced liver disease - ScienceDirect
A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes
Membrane-bound O-acyltransferase 7 (MBOAT7)-driven phosphatidylinositol remodeling in advanced liver disease - ScienceDirect
Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice - ScienceDirect
Enhancing Hepatic MBOAT7 Expression in Mice With Nonalcoholic Steatohepatitis - ScienceDirect
Frontiers MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population
Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver - ScienceDirect
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis - ScienceDirect
